表紙
市場調查報告書

深層腦部刺激器:醫療設備的開發平台評估

Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 347932
出版日期 內容資訊 英文 164 Pages
訂單完成後即時交付
價格
深層腦部刺激器:醫療設備的開發平台評估 Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 164 Pages
簡介

本報告提供深層腦部刺激器的開發中產品調查分析,以各開發階段比較分析為焦點,提供您正在開發開發中產品的主要企業,以及進行中的臨床試驗相關之系統性資訊。

第1章 目錄

第2章 簡介

  • 深層腦部刺激器概要

第3章 開發中的產品

  • 深層腦部刺激器 - 開發中產品:各開發階段
  • 深層腦部刺激器 - 開發中產品:各地區
  • 深層腦部刺激器 - 開發中產品:法規別
  • 深層腦部刺激器 - 開發中產品:核准預定日別
  • 深層腦部刺激器 - 進行中的臨床試驗

第4章 深層腦部刺激器 - 正在開發的開發中產品:各企業

  • 深層腦部刺激器企業 - 開發中產品:各開發階段
  • 深層腦部刺激器 - 開發中產品:各開發階段

第5章 深層腦部刺激器企業與產品概要

  • Adaptive Neuromodulation GmbH
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Brainsway Ltd.
  • Cerene Biomedics, Inc
  • Children's Hospital Boston
  • Cleveland Medical Devices, Inc.
  • Clinatec
  • Deep Brain Innovations, LLC
  • Duke University
  • Functional Neuromodulation Inc.
  • Highland Instruments, Inc.
  • Massachusetts General Hospital
  • Mayo Clinic.
  • Medtronic plc
  • National Cheng-Kung University Hospital
  • NeuroPro Technologies, Inc.
  • NeuroSigma, Inc.
  • Nuraleve Inc.
  • Soterix Medical Inc
  • St. Jude Medical, Inc.
  • SUNY Downstate Medical Center
  • The University of Utah
  • University of California, Los Angeles
  • University of Central Florida
  • University of Illinois
  • University of Milan
  • University of Oxford
  • University of South Florida
  • Wedge Therapeutics

第6章 深層腦部刺激器 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0850EPD

GlobalData's Medical Devices sector report, "Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019" provides an overview of Deep Brain Stimulators (DBS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators (DBS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators (DBS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 6
  • 1.2 List of Figures 10

2 Introduction 11

  • 2.1 Deep Brain Stimulators (DBS) Overview 11

3 Products under Development 12

  • 3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development 12
  • 3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory 13
  • 3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path 14
  • 3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date 15
  • 3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials 16

4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies 17

  • 4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development 17
  • 4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development 19

5 Deep Brain Stimulators (DBS) Companies and Product Overview 21

  • 5.1 Adaptive Neuromodulation GmbH Company Overview 21
    • 5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.2 Adept Neuro SA Company Overview 22
    • 5.2.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.3 Aleva Neurotherapeutics SA Company Overview 23
    • 5.3.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.4 Baylor College of Medicine Company Overview 24
    • 5.4.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.5 Bioinduction Limited Company Overview 25
    • 5.5.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.6 Boston Scientific Corp Company Overview 28
    • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.7 Brainsway Ltd Company Overview 34
    • 5.7.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.8 Cleveland Medical Devices Inc Company Overview 41
    • 5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.9 Clinatec Company Overview 42
    • 5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.10 Cortera Neurotechnologies Inc Company Overview 43
    • 5.10.1 Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.11 Deep Brain Innovations, LLC Company Overview 44
    • 5.11.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.12 Enspire DBS Therapy Inc Company Overview 49
    • 5.12.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.13 Functional Neuromodulation Inc. Company Overview 52
    • 5.13.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.14 Louisiana State University Company Overview 57
    • 5.14.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.15 Massachusetts General Hospital Company Overview 58
    • 5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.16 Massachusetts Institute of Technology Company Overview 60
    • 5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.17 Medtronic plc Company Overview 61
    • 5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.18 National Cheng-Kung University Hospital Company Overview 65
    • 5.18.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.19 NeuroOne Inc Company Overview 66
    • 5.19.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.20 Neuroparticle Corp Company Overview 67
    • 5.20.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.21 NeuroPro Technologies Inc Company Overview 68
    • 5.21.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.22 Neurosigma Inc Company Overview 69
    • 5.22.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.23 Newronika s.r.l. Company Overview 71
    • 5.23.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.24 Nexeon MedSystems Inc Company Overview 74
    • 5.24.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 76
    • 5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.26 St. Jude Medical LLC Company Overview 77
    • 5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.27 Sunnybrook Health Sciences Centre Company Overview 82
    • 5.27.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.28 SUNY Downstate Medical Center Company Overview 85
    • 5.28.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.29 University of California Los Angeles Company Overview 86
    • 5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.30 University of Central Florida Company Overview 88
    • 5.30.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.31 University of Florida Company Overview 89
    • 5.31.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.32 University of Houston Company Overview 91
    • 5.32.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.33 University of Illinois Company Overview 92
    • 5.33.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.34 University of Milan Company Overview 93
    • 5.34.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.35 University of Minnesota Company Overview 94
    • 5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.36 University of Oxford Company Overview 95
    • 5.36.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.37 University of Rochester Company Overview 96
    • 5.37.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.38 University of South Florida Company Overview 97
    • 5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.39 Wedge Therapeutics Company Overview 98
    • 5.39.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 98

6 Deep Brain Stimulators (DBS)- Recent Developments 99

  • 6.1 Nov 25, 2019: BrainsWay reports third quarter 2019 financial results and operational highlights 99
  • 6.2 Nov 25, 2019: BrainsWay appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer 100
  • 6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 101
  • 6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 103
  • 6.5 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) 104

7 Appendix 161

  • 7.1 Methodology 161
  • 7.2 About GlobalData 164
  • 7.3 Contact Us 164
  • 7.4 Disclaimer 164

List of Tables

  • Table 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Table 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Table 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Table 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Table 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
  • Table 6: Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
  • Table 7: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: CR-Capable Implant - Product Status
  • Table 10: CR-Capable Implant - Product Description
  • Table 11: Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Stereo-Electro-Encephalo-Graphie Electrode - Product Status
  • Table 13: Stereo-Electro-Encephalo-Graphie Electrode - Product Description
  • Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: directSTIM - Product Status
  • Table 16: directSTIM - Product Description
  • Table 17: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Adaptive Deep Brain Stimulation (aDBS) Device - Product Status
  • Table 19: Adaptive Deep Brain Stimulation (aDBS) Device - Product Description
  • Table 20: Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Picostim - Product Status
  • Table 22: Picostim - Product Description
  • Table 23: Bioinduction Limited - Ongoing Clinical Trials Overview
  • Table 24: Picostim - Simpler and Safer Deep Brain Stimulation for Parkinson's Disease
  • Table 25: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
  • Table 27: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
  • Table 28: Next Generation DBS System - Product Status
  • Table 29: Next Generation DBS System - Product Description
  • Table 30: Vercise Deep Brain Stimulation System - Dystonia - Product Status
  • Table 31: Vercise Deep Brain Stimulation System - Dystonia - Product Description
  • Table 32: Vercise Deep Brain Stimulation System - Tremors - Product Status
  • Table 33: Vercise Deep Brain Stimulation System - Tremors - Product Description
  • Table 34: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 35: Vercise Deep Brain Stimulation System - Dystonia - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
  • Table 36: Vercise Deep Brain Stimulation System - Dystonia - Registry of Deep Brain Stimulation with the Vercise System for Treatment of Dystonia: Vercise DBS Dystonia Registry
  • Table 37: Vercise Deep Brain Stimulation System - Dystonia - Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
  • Table 38: Vercise Deep Brain Stimulation System - Tremors - Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET): ET Registry
  • Table 39: Vercise Deep Brain Stimulation System - Tremors - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
  • Table 40: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Deep TMS System - Alzheimer's Disease - Product Status
  • Table 42: Deep TMS System - Alzheimer's Disease - Product Description
  • Table 43: Deep TMS System - Bipolar Disorder - Product Status
  • Table 44: Deep TMS System - Bipolar Disorder - Product Description
  • Table 45: Deep TMS System - PTSD - Product Status
  • Table 46: Deep TMS System - PTSD - Product Description
  • Table 47: Deep TMS System - Smoking Cessation - Product Status
  • Table 48: Deep TMS System - Smoking Cessation - Product Description
  • Table 49: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Status
  • Table 50: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Description
  • Table 51: Brainsway Ltd - Ongoing Clinical Trials Overview
  • Table 52: Deep TMS System - Bipolar Disorder - A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression
  • Table 53: Deep TMS System - PTSD - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-traumatic Stress Disorder (PTSD)
  • Table 54: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: ParkinTune - Product Status
  • Table 56: ParkinTune - Product Description
  • Table 57: Clinatec Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Intracranial Deep Brain Stimulation Device - Product Status
  • Table 59: Intracranial Deep Brain Stimulation Device - Product Description
  • Table 60: Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: WAND - Product Status
  • Table 62: WAND - Product Description
  • Table 63: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: TOPS Device - Alzheimer's disease - Product Status
  • Table 65: TOPS Device - Alzheimer's disease - Product Description
  • Table 66: TOPS Device - Depression - Product Status
  • Table 67: TOPS Device - Depression - Product Description
  • Table 68: TOPS Device - Epilepsy - Product Status
  • Table 69: TOPS Device - Epilepsy - Product Description
  • Table 70: TOPS Device - Obesity - Product Status
  • Table 71: TOPS Device - Obesity - Product Description

List of Figures

  • Figure 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Figure 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Figure 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Figure 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Figure 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials